US drugmaker Eli Lilly and Company announced that it was slashing prices of its most commonly-prescribed insulins by 70 percent. Lilly said it would cut the price of its non-branded insulin to $25 a vial from May 1. It will also cut the price of Humalog, the company’s most commonly-prescribed insulin and Humalin injections by 70 percent towards the end of the year.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Met Office predicts ‘severe heatwave conditions’

On Friday, the Pakistan Meteorological Department forecasted “severe heatwave conditions” across Pakistan…

Asad Umer alarmed the public of Pakistan regarding the 4th wave of coronavirus

Head of National Command and Operation Centre (NCOC), Asad Umar, said that…

Two-day pharma and healthcare expo kickstarts

Lahore: Pak Pharma and Healthcare expo in collaboration with the Pakistan Pharmaceutical…

US, Germany agree on Omicron limitations

Berlin/Washington: Germany announced on Thursday to latch the unvaccinated from the most…